Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
89.72
+0.40 (0.45%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Edwards Lifesciences Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 6,512 | 6,068 | 5,440 | 5,010 | 4,464 | 5,233 |
Revenue Growth | 14.55% | 11.55% | 8.57% | 12.23% | -14.69% | 19.29% |
Gross Profit Gross Profit Growth | 5,069 | 4,733 | 4,322 | 4,032 | 3,740 | 3,984 |
Operating Income Operating Income Growth | 1,449 | 1,264 | 1,379 | 1,309 | 1,498 | 1,690 |
Net Income Net Income Growth | 1,005 | 1,074 | 4,175 | 1,402 | 1,522 | 1,503 |
Earnings Per Share EPS Growth | 1.74 | 1.83 | 6.97 | 2.30 | 2.44 | 2.38 |
EPS Growth | -74.96% | -73.75% | 203.04% | -5.74% | 2.52% | 83.08% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Transcatheter Aortic Valve Replacement Transcatheter Aortic Valve Replacement Growth | 4,766 | 4,488 | 4,106 | 3,880 | 3,518 | 3,423 |
Transcatheter Mitral and Tricuspid Therapies Transcatheter Mitral and Tricuspid Therapies Growth | 674.6 | 550.6 | 352.1 | 197.6 | 116.1 | 86 |
Surgical Structural Heart Surgical Structural Heart Growth | 1,072 | 1,029 | 981.3 | 932.6 | 829.7 | 889.1 |
Revenue (Total) Revenue (Total) Growth | 6,512 | 6,068 | 5,440 | 5,010 | 4,464 | 5,233 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 4,253 | 4,226 | 3,976 | 1,633 | 1,215 | 1,467 |
Total Debt Total Debt Growth | 704.4 | 705.4 | 700 | 685.1 | 691.3 | 690.3 |
Net Cash (Debt) Net Cash Growth | 3,548 | 3,521 | 3,276 | 947.7 | 524 | 776.5 |
Net Cash Growth | 5.62% | 7.48% | 245.67% | 80.86% | -32.52% | 9.72% |
Net Cash Per Share Net Cash Per Share Growth | 6.10 | 6.01 | 5.47 | 1.56 | 0.84 | 1.23 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,720 | 1,595 | 542.3 | 895.8 | 1,218 | 1,732 |
Capital Expenditures CapEx Growth | -286.7 | -260.2 | -252.4 | -253 | -244.6 | -325.8 |
Free Cash Flow Free Cash Flow Growth | 1,434 | 1,335 | 289.9 | 642.8 | 973.6 | 1,406 |
Free Cash Flow Growth | 143.85% | 360.50% | -54.90% | -33.98% | -30.77% | 117.26% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 77.84% | 78.01% | 79.46% | 80.47% | 83.79% | 76.13% |
Operating Margin | 22.25% | 20.84% | 25.35% | 26.13% | 33.57% | 32.30% |
Pretax Margin | 21.77% | 20.98% | 28.46% | 27.39% | 34.04% | 32.53% |
Profit Margin | 15.03% | 17.40% | 25.66% | 24.35% | 29.66% | 28.73% |
FCF Margin | 22.01% | 22.00% | 5.33% | 12.83% | 21.81% | 26.88% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 53.53 | 46.58 | 10.62 | 33.15 | 30.58 | 54.43 |
Forward PE | 28.58 | 30.93 | 31.19 | 28.41 | 30.35 | 52.98 |
P/FCF Ratio | 36.07 | 37.08 | 150.31 | 71.30 | 46.62 | 57.49 |
PS Ratio | 7.94 | 8.16 | 8.01 | 9.15 | 10.17 | 15.45 |